Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
804,525
-
Total 13F shares
-
100,918
-
Share change
-
-14,910
-
Total reported value
-
$109,292
-
Price per share
-
$1.08
-
Number of holders
-
12
-
Value change
-
-$123,996
-
Number of buys
-
6
-
Number of sells
-
3
Institutional Holders of InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) as of Q1 2023
As of 31 Mar 2023,
InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
100,918 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, BANK OF AMERICA CORP /DE/, BlackRock Inc., ADVISOR GROUP HOLDINGS, INC., AllSquare Wealth Management LLC, Federation des caisses Desjardins du Quebec, NATIONAL BANK OF CANADA /FI/, and Advisory Services Network, LLC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.